Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Phase I data on the pharmacokinetics and safety of CR-002

Nov. 14, 2005

KRP-103: A new NK1 antagonist for urinary incontinence

Nov. 10, 2005

Not approvable letter for premature ejaculation drug dapoxetine

Nov. 9, 2005

Novel therapeutics for genitourinary disorders claimed in recent Roche patent

Nov. 3, 2005

DPI-221 shows potential as an agent for overactive bladder and urinary incontinence

Nov. 2, 2005

Kyorin executes license with LG Life Sciences for KRP-197

Oct. 31, 2005

Phase II data on tadalafil in the treatment of BPH

Oct. 17, 2005

Rho kinase inhibitor improves responses of the cavernosal smooth muscle in rats

Oct. 14, 2005

Chugai patent describes new vitamin D receptor agonists for urological disorders

Oct. 14, 2005

Urigen receives IND clearance for phase IIb study of U-101

Oct. 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...